For research use only. Not for therapeutic Use.
DHODH-IN-17, a 2-anilino nicotinic acid, is a human DHODH inhibitor (IC50=0.40 μM). DHODH-IN-17 can be used for theresearch of acute myeloid leukemia (AML)[1].
DHODH-IN-17, a 2-anilino nicotinic acid, is a human DHODH inhibitor with an IC50 value of 0.40 μM[1].
Catalog Number | M134579 |
CAS Number | 16344-26-6 |
Synonyms | 2-(4-chloroanilino)pyridine-3-carboxylic acid |
Molecular Formula | C12H9ClN2O2 |
Purity | ≥95% |
InChI | InChI=1S/C12H9ClN2O2/c13-8-3-5-9(6-4-8)15-11-10(12(16)17)2-1-7-14-11/h1-7H,(H,14,15)(H,16,17) |
InChIKey | YEXIXVLEDGNAKM-UHFFFAOYSA-N |
SMILES | C1=CC(=C(N=C1)NC2=CC=C(C=C2)Cl)C(=O)O |
Reference | [1]. Lewis TA, et al. Development of ML390: A Human DHODH Inhibitor That Induces Differentiation in Acute Myeloid Leukemia. ACS Med Chem Lett. 2016;7(12):1112-1117. |